Jason Shafrin, PhD

Payer Perceptions of Genomic Precision Medicine
Healthcare Economist
Payer Perceptions of Genomic Precision Medicine
05/20/2020
Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide coverage for genetic tests as well as how they value these factors.
Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide coverage for genetic tests as well as how they value these factors.
Jason Shafrin, PhD, highlights a...
05/20/2020
Journal of Clinical Pathways
Healthcare Economist
Clinician-Directed Performance Improvement Is the Best Way to Improve Quality, So Why Won’t Payers Use It?
02/14/2020
Jason Shafrin, PhD, argues that clinician-directed performance improvement provides clear advantages, but payers are unlikely to be interested in this QI approach.
Jason Shafrin, PhD, argues that clinician-directed performance improvement provides clear advantages, but payers are unlikely to be interested in this QI approach.
Jason Shafrin, PhD, argues that...
02/14/2020
Journal of Clinical Pathways
Healthcare Economist
Measuring the Value of Pharmaceuticals Over Time
02/27/2019
Jason Shafrin, PhD, explains the difficulty of measuring pharmaceutical value and notes ways in which ICER and IVI are attempting to address this challenge.
Jason Shafrin, PhD, explains the difficulty of measuring pharmaceutical value and notes ways in which ICER and IVI are attempting to address this challenge.
Jason Shafrin, PhD, explains the...
02/27/2019
Journal of Clinical Pathways
Healthcare Economist
Does a Drug’s Cost-Effectiveness Improve Over Time?
03/24/2020
Jason Shafrin, PhD, points to a recent study that shows clinical and cost effectiveness of a drug may improve over time; he asserts that this finding should be of importance to policymakers and payers.
Jason Shafrin, PhD, points to a recent study that shows clinical and cost effectiveness of a drug may improve over time; he asserts that this finding should be of importance to policymakers and payers.
Jason Shafrin, PhD, points to a...
03/24/2020
Journal of Clinical Pathways
Healthcare Economist
Understanding Price Growth in the Market for Targeted Oncology Therapies
06/20/2019
Jason Shafrin, PhD, asserts that patients and payers can justifiably complain about the rising prices of targeted therapies, but manufacturers can rightfully argue that the prices need to be this high to maintain revenues.
Jason Shafrin, PhD, asserts that patients and payers can justifiably complain about the rising prices of targeted therapies, but manufacturers can rightfully argue that the prices need to be this high to maintain revenues.
Jason Shafrin, PhD, asserts that...
06/20/2019
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
Hospitalization Risk among Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics: A Long-Term Retrospective Analysis of Medicaid Claims Data
Objective: To compare the risk of hospitalization for adults with bipolar I disorder (BPD-I) when treated with lurasidone vs. other atypical antipsychotics (AAPs) as monotherapy.
10/08/2020
Healthcare Economist
What Is a Patient-Informed Societal Perspective CEA Model?
06/28/2019
Jason Shafrin, PhD, sheds light on a study that argues that patients are underrepresented in traditional cost-effectiveness analysis and that a patient-informed societal perspective is needed.
Jason Shafrin, PhD, sheds light on a study that argues that patients are underrepresented in traditional cost-effectiveness analysis and that a patient-informed societal perspective is needed.
Jason Shafrin, PhD, sheds light...
06/28/2019
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use